• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Elucidating Durable Responses to Immune Checkpoint Inhibition.

作者信息

Rescigno Pasquale, Aversa Caterina, Crespo Mateus, Seed George, Lambros Maryou, Gurel Bora, Figueiredo Ines, Bianchini Diletta, Riisnaes Ruth, Pereira Rita, Fenor de la Maza Maria D, Carmichael Juliet, Chandran Khobe, Ferreira Ana, Bertan Claudia, Paschalis Alec, Curcean Andra, Sharp Adam, Yuan Wei, Tunariu Nina, Poehlein Christian, Carreira Suzanne, de Bono Johann S

机构信息

The Institute of Cancer Research, London, UK; The Royal Marsden Hospital, London, UK.

The Institute of Cancer Research, London, UK.

出版信息

Eur Urol. 2020 Oct;78(4):639-641. doi: 10.1016/j.eururo.2020.06.056. Epub 2020 Jul 9.

DOI:10.1016/j.eururo.2020.06.056
PMID:32653323
Abstract
摘要

相似文献

1
Elucidating Durable Responses to Immune Checkpoint Inhibition.阐明对免疫检查点抑制的持久反应。
Eur Urol. 2020 Oct;78(4):639-641. doi: 10.1016/j.eururo.2020.06.056. Epub 2020 Jul 9.
2
The challenge of checkpoint inhibitors in prostate cancer: drugs for the many but useful to a few.前列腺癌中检查点抑制剂面临的挑战：适用于多数人的药物但仅对少数人有用。
Immunotherapy. 2020 Mar;12(4):219-221. doi: 10.2217/imt-2019-0221. Epub 2020 Mar 16.
3
Favorable Response to Pembrolizumab in a Patient With Metastatic Castration-Resistant Prostate Cancer Progressing While Receiving Enzalutamide.一名在接受恩杂鲁胺治疗期间病情进展的转移性去势抵抗性前列腺癌患者对帕博利珠单抗产生良好反应。
Clin Genitourin Cancer. 2019 Apr;17(2):e365-e368. doi: 10.1016/j.clgc.2018.11.021. Epub 2018 Dec 6.
4
Complete and durable response to immune checkpoint inhibitor in a patient with refractory and metastatic hepatoblastoma.患者肝母细胞瘤难治性和转移性，对免疫检查点抑制剂有完全和持久应答。
Pediatr Hematol Oncol. 2021 May;38(4):385-390. doi: 10.1080/08880018.2020.1853859. Epub 2021 Feb 27.
5
Is there a role for immune checkpoint inhibitors in selected rare subtypes of soft tissue sarcoma?免疫检查点抑制剂在特定罕见亚型软组织肉瘤中是否有作用？
Immunotherapy. 2021 Feb;13(2):91-93. doi: 10.2217/imt-2020-0301. Epub 2020 Dec 9.
6
Immune checkpoint inhibitors in women with gynecologic cancers: Practical considerations.妇科恶性肿瘤患者的免疫检查点抑制剂：实用考虑因素。
Gynecol Oncol. 2020 Sep;158(3):531-537. doi: 10.1016/j.ygyno.2020.06.499. Epub 2020 Jul 5.
7
Exceptional Response to Pembrolizumab in a Patient With Castration-Resistant Prostate Cancer With Pancytopenia From Myelophthisis.帕博利珠单抗对一名因骨髓痨导致全血细胞减少的去势抵抗性前列腺癌患者产生显著疗效。
J Oncol Pract. 2019 Jun;15(6):343-345. doi: 10.1200/JOP.19.00012. Epub 2019 Apr 9.
8
Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.癌症免疫检查点抑制剂治疗开始后出现亚急性皮肤型红斑狼疮。
Lupus. 2021 Mar;30(3):531-533. doi: 10.1177/0961203320983448. Epub 2021 Jan 6.
9
Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum.着色性干皮病中皮肤鳞状细胞癌预防的免疫治疗策略。
Br J Dermatol. 2019 Nov;181(5):1095-1097. doi: 10.1111/bjd.18144. Epub 2019 Aug 7.
10
Pursuing efficacious systemic therapy for hepatocellular carcinoma.寻求针对肝细胞癌的有效全身治疗方法。
Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):95-96. doi: 10.1038/s41575-020-00405-1.

引用本文的文献

1
GAS1RR, an immune-related enhancer RNA, is related to biochemical recurrence-free survival in prostate cancer.GAS1RR，一种免疫相关增强子 RNA，与前列腺癌的生化无复发生存相关。
Exp Biol Med (Maywood). 2023 Jan;248(1):1-13. doi: 10.1177/15353702221131888. Epub 2022 Nov 20.
2
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives.晚期前列腺癌中的免疫检查点抑制剂：当前数据与未来展望
Cancers (Basel). 2022 Feb 28;14(5):1245. doi: 10.3390/cancers14051245.